Aperture AC posts $125K Q3 net income on interest
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Aperture AC reported net income of $125,062 for the quarter ended September 30, 2026, including $937,605 of interest earned on Trust Account securities, while operating expenses were $816,210. The blank-check company had not begun operations or generated operating revenue; it had $172,161 in cash and $103,549,504 in Trust Account marketable securities at September 30, 2026.
Under a September 10, 2026 agreement, Aperture AC would redomicile in Delaware and merge with Atlantic HPC Group Inc.; Atlantic would become its wholly owned subsidiary. Atlantic stockholders would receive $150 million in Aperture AC common stock, valued at $10 per share. The agreement also allows up to 6,000,000 additional shares if stated earnout milestones are met, including 3,000,000 shares for a qualifying lease of the data center’s full five-megawatt Phase I capacity for at least seven years. Completion remains subject to agreement conditions and shareholder approval. Aperture AC has until May 22, 2027, unless its board sets an earlier date or shareholders approve an extension.
Filing Explained
At a closing, each right carries a quarter-share entitlement, while founder conversion may adjust toward 27 percent of a defined share base.
A 10-Q is an unaudited quarterly report; this filing adds holder mechanics to the contemplated Atlantic merger: rights can deliver shares at closing, and founder-share conversion can adjust based on issuance and redemptions.
The IPO included 10.2 million public units and 311,000 private-placement units, each carrying a right to receive one-quarter of a Class A share when a business combination closes. If no combination is completed, the rights expire without value.
No fractional shares are issued for rights; a holder must have rights in multiples of four to receive shares for all of them. Issuing rights shares would increase the total share count and reduce existing holders’ percentage ownership, absent offsetting changes.
As of
Key Figures
Key Terms
temporary equity financial
Earnout Shares financial
Share Price Milestones financial
public float financial
Level 1 inputs financial
redemption value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the proposed APUR-Atlantic merger consideration?
How many additional shares could Atlantic stockholders receive under the APUR earnout?
What lease qualifies for the APUR Atlantic earnout?
When does APUR have to complete a business combination?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| (Mark One) |
| For the quarterly period ended |
| or |
| For the transition period from to |
Commission File Number:
(Exact name of registrant as specified in its charter)
| N/A | ||
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The | ||||
| The | ||||
| Rights, each entitling the holder to receive one-fourth (1/4) of one Class A Ordinary Share upon the consummation of an initial Business Combination | The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ | |
| Smaller reporting company | ||
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of November 13, 2026, there were
APERTURE AC
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026
TABLE OF CONTENTS
| Page | ||
| PART I – FINANCIAL INFORMATION | ||
| Item 1. | Financial Statements. | 1 |
| Unaudited Balance Sheets as of September 30, 2026 and December 31, 2025 | 1 | |
| Unaudited Statements of Operations for the Three and Nine Months Ended September 30, 2026 and for the Period from September 10, 2025 (Inception) through September 30, 2025 | 2 | |
| Unaudited Statements of Changes in Shareholders’ Equity (Deficit) for the Three and Nine Months Ended September 30, 2026 and for the Period from September 10, 2025 (Inception) through September 30, 2025 | 3 | |
| Unaudited Statements of Cash Flows for the Nine Months Ended September 30, 2026 and for the Period from September 10, 2025 (Inception) through September 30, 2025 | 4 | |
| Notes to Unaudited Financial Statements | 5 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 23 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk. | 33 |
| Item 4. | Controls and Procedures. | 33 |
| PART II – OTHER INFORMATION | ||
| Item 1. | Legal Proceedings. | 34 |
| Item 1A. | Risk Factors. | 34 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. | 34 |
| Item 3. | Defaults Upon Senior Securities. | 35 |
| Item 4. | Mine Safety Disclosures. | 35 |
| Item 5. | Other Information. | 35 |
| Item 6. | Exhibits. | 36 |
| SIGNATURES | 37 | |
i
Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:
| ● | “Administrative Services Agreement” are to the Administrative Services Agreement, dated May 20, 2026, which we entered into with our Sponsor (as defined below); |
| ● | “Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as currently in effect; |
| ● | “ASC” are to the FASB (as defined below) Accounting Standards Codification; |
| ● | “ASU” are to the FASB Accounting Standards Update; |
| ● | “Atlantic” are to Atlantic HPC Group Inc, a Delaware corporation;
| |
| ● | “Atlantic BCA” are to the Business Combination Agreement, dated September 10, 2026, we entered into with (i) Atlantic and (ii) Merger Sub;
| |
| ● | “Atlantic Business Combination” are to the transactions contemplated by the Atlantic BCA and the related ancillary documents, collectively;
| |
| ● | “Atlantic Registration Statement” are to the Registration Statement on Form S-4 to be filed with the SEC in connection with the Atlantic Business Combination, which will include a preliminary proxy statement/prospectus; |
| ● | “Board of Directors” or “Board” are to our board of directors; |
| ● | “Business Combination” are to a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses; |
| ● | “Certifying Officers” are to our Chief Executive Officer and Chief Financial Officer, together; |
| ● | “Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share; |
| ● | “Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share; |
| ● | “Combination Period” are to (i) the 12-month period, from the closing of the Initial Public Offering (as defined below) to May 22, 2027 (or such earlier date as determined by the Board), that we have to consummate an initial Business Combination, or (ii) such other period during which we must consummate an initial Business Combination pursuant to an amendment to the Amended and Restated Articles and consistent with applicable laws, regulations and stock exchange rules; |
| ● | “Company,” “our,” “we” or “us” are to Aperture AC, a Cayman Islands exempted company; |
| ● | “Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account (as defined below) and rights agent of our Rights (as defined below); |
| ● | “EarlyBirdCapital” are to EarlyBirdCapital, Inc., one of the Underwriters (as defined below); |
| ● | “Exchange Act” are to the Securities Exchange Act of 1934, as amended; |
| ● | “FASB” are to the Financial Accounting Standards Board; |
| ● | “Founder Shares” are (i) to the 3,828,082 Class B Ordinary Shares initially purchased by our Sponsor prior to the Initial Public Offering and (ii) Class A Ordinary Shares that will be issued upon the automatic conversion of the Class B Ordinary Shares (x) at the time of our Business Combination as described in the IPO Registration Statement (as defined below) or (y) earlier at the option of the holders thereof, as described in the IPO Registration Statement; for the avoidance of doubt, such Class A Ordinary Shares will not be “Public Shares” (as defined below); |
| ● | “GAAP” are to the accounting principles generally accepted in the United States of America; |
| ● | “I-Bankers” are to I-Bankers Securities, Inc, one of the Underwriters; |
| ● | “IB Capital” are to IB Capital LLC, one of and the representative of the Underwriters; |
ii
| ● | “Initial Public Offering” or “IPO” are to the initial public offering that we consummated on May 22, 2026; |
| ● | “Investment Company Act” are to the Investment Company Act of 1940, as amended; |
| ● | “IPO Promissory Note” are to that certain unsecured promissory note in the principal amount of up to $500,000 issued to our Sponsor on September 30, 2025; |
| ● | “IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC (as defined below) on November 17, 2025, as amended, and declared effective on May 14, 2026 (File No. 333-291583); |
| ● | “Letter Agreement” are to the Letter Agreement, dated May 20, 2026, which we entered into with our Sponsor, directors and officers; |
| ● | “Management” or our “Management Team” are to our executive officers and directors; |
| ● | “Merger Sub” are to AP Ocean Merger Sub, Inc., a Delaware corporation and our direct wholly owned subsidiary; |
| ● | “Nasdaq” are to The Nasdaq Stock Market LLC; |
| ● | “Nasdaq 36-Month Requirement” are to the requirement pursuant to the Nasdaq Rules (as defined below) that a SPAC (as defined below) must complete one or more Business Combinations within 36 months following the effectiveness of its initial public offering registration statement; |
| ● | “Nasdaq Rules” are to the continued listing rules of Nasdaq, as they exist as of the date of this Report; |
| ● | “Option Units” are to the 1,200,000 units that were purchased by the Underwriters pursuant to the partial exercise of the Over-Allotment Option (as defined below); |
| ● | “Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together; |
| ● | “Over-Allotment Option” are to the 30-day option that the Underwriters had to purchase up to an additional 1,350,000 Option Units to cover over-allotments, if any, pursuant to the Underwriting Agreement (as defined below), which was partially exercised; |
| ● | “Private Placement” are to the private placement of Private Placement Units (as defined below) that occurred simultaneously with the closing of our Initial Public Offering, pursuant to the Private Placement Units Purchase Agreements (as defined below); |
| ● | “Private Placement Rights” are to the rights included within the Private Placement Units purchased by our Sponsor and the Underwriters in the Private Placement; |
| ● | “Private Placement Shares” are to the Class A Ordinary Shares included within the Private Placement Units purchased by our Sponsor and the Underwriters in the Private Placement; |
| ● | “Private Placement Units” are to the units purchased by our Sponsor and the Underwriters in the Private Placement; |
| ● | “Private Placement Units Purchase Agreements” are to the (i) Private Placement Units Purchase Agreement, dated May 20, 2026, which we entered into with our Sponsor and (ii) Private Placement Units Purchase Agreement, dated May 20, 2026, which we entered into with the Underwriters, together; |
| ● | “Public Rights” are to the rights included as part of the Public Units (as defined below), which grant the holder the right to receive one-fourth (1/4) of one Class A Ordinary Share upon the consummation of the Business Combination; |
iii
| ● | “Public Shareholders” are to the holders of our Public Shares, including our Sponsor and Management Team to the extent our Sponsor and/or the members of our Management Team purchase Public Shares, provided that our Sponsor’s and each member of our Management Team’s status as a “Public Shareholder” will only exist with respect to such Public Shares; |
| ● | “Public Shares” are to the Class A Ordinary Shares included as part of the Public Units (whether they were purchased in our Initial Public Offering or thereafter in the open market); |
| ● | “Public Units” are to the units sold in our Initial Public Offering, with each Public Unit consisting of one Public Share and one Public Right; |
| ● | “Registration Rights Agreement” are to the Registration Rights Agreement, dated May 20, 2026, which we entered into with the Sponsor and the other holders party thereto; |
| ● | “Representative Shares” are to the 450,000 Class A Ordinary Shares that were issued to IB Capital for a purchase price of $0.01 per share; |
| ● | “Report” are to this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026; |
| ● | “Rights” are to the Private Placement Rights and the Public Rights, together; |
| ● | “Rights Agreement” are to the Share Rights Agreement, dated May 20, 2026, which we entered into with Continental, as Rights agent; |
| ● | “SEC” are to the U.S. Securities and Exchange Commission; |
| ● | “Securities Act” are to the Securities Act of 1933, as amended; |
| ● | “SPAC” are to a special purpose acquisition company; |
| ● | “Sponsor” are to Aperture Sponsor LLC, a Delaware limited liability company; |
| ● | “Trust Account” are to the U.S.-based trust account in which an amount of $102,255,000 from the net proceeds of the sale of the Public Units in the Initial Public Offering and the Private Placement Units in the Private Placement was placed following the closing of the Initial Public Offering; |
| ● | “Trust Agreement” are to the Investment Management Trust Agreement, dated May 20, 2026, which we entered into with Continental, as trustee of the Trust Account; |
| ● | “Underwriters” are to EarlyBirdCapital, IB Capital and I-Bankers, the several underwriters of the Initial Public Offering, collectively; |
| ● | “Underwriting Agreement” are to the Underwriting Agreement, dated May 20, 2026, which we entered into with IB Capital, as representative of the Underwriters; |
| ● | “Units” are to the Private Placement Units and the Public Units, together; and |
| ● | “Working Capital Loans” are to funds that, in order to provide working capital or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our directors and officers may, but are not obligated to, loan us. |
iv
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements.
APERTURE AC
UNAUDITED BALANCE SHEETS
| September 30, 2026 |
December 31, 2025 |
|||||||
| Assets: | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Prepaid expenses - current | ||||||||
| Due from related party | — | |||||||
| Total current assets | ||||||||
| Deferred offering costs | — | |||||||
| Marketable securities held in Trust Account | — | |||||||
| Total Assets | $ | $ | ||||||
| Liabilities and Shareholders’ Equity (Deficit): | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued expenses | — | |||||||
| Accrued offering costs | — | |||||||
| IPO Promissory Note – related party | — | |||||||
| Total current liabilities | ||||||||
| Total Liabilities | ||||||||
| Commitments and Contingencies (Note 7) | ||||||||
| Class A Ordinary Shares subject to possible redemption, $ | — | |||||||
| Shareholders’ Deficit | ||||||||
| Preference shares, $ | — | — | ||||||
| Class A Ordinary Shares, $ | — | |||||||
| Class B Ordinary Shares, $ | ||||||||
| Additional paid-in capital | — | |||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total Shareholders’ Deficit | ( | ) | ( | ) | ||||
| Total Liabilities and Shareholders’ Deficit | $ | $ | ||||||
| (1) | |
| (2) |
The accompanying notes are an integral part of these unaudited financial statements.
1
APERTURE AC
UNAUDITED STATEMENTS OF OPERATIONS
| Three Months Ended September 30, 2026 |
Nine Months Ended September 30, 2026 |
For the Period From September 10, 2025 (Inception) Through September 30, 2025 |
||||||||||
| Operating expenses: | ||||||||||||
| Formation, general and administrative expenses | $ | $ | $ | |||||||||
| Legal and accounting expenses | — | |||||||||||
| Insurance expense | ||||||||||||
| Listing fees | ||||||||||||
| Administrative services fee – related party | — | |||||||||||
| Total operating expenses | ( | ) | ( | ) | ( | ) | ||||||
| Loss from operations | ( | ) | ( | ) | ( | ) | ||||||
| Other income: | ||||||||||||
| Interest earned on bank account | — | |||||||||||
| Interest earned on marketable securities held in Trust Account | — | |||||||||||
| Total other income | — | |||||||||||
| Net income (loss) | $ | $ | $ | ( | ) | |||||||
| Basic and diluted weighted average shares outstanding of redeemable Class A Ordinary Shares | — | |||||||||||
| Basic and diluted net income (loss) per share, redeemable Class A Ordinary Shares | $ | $ | $ | — | ||||||||
| Basic and diluted weighted average shares outstanding of non-redeemable Class A Ordinary Shares | — | |||||||||||
| Basic and diluted net income (loss) per share, non-redeemable Class A Ordinary Shares | $ | $ | $ | — | ||||||||
| Basic weighted average shares outstanding of non-redeemable Class B Ordinary Shares (1)(2) | ||||||||||||
| Basic net income (loss) per share, non-redeemable Class B Ordinary Shares | $ | $ | $ | ( | ) | |||||||
| Diluted weighted average shares outstanding of non-redeemable Class B Ordinary Shares (1)(2) | ||||||||||||
| Diluted net income (loss) per share, non-redeemable Class B Ordinary Shares | $ | $ | $ | ( | ) | |||||||
| (1) | |
| (2) |
The accompanying notes are an integral part of these unaudited financial statements.
2
APERTURE AC
UNAUDITED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026
| Class A ordinary shares subject to possible redemption |
Class A ordinary shares |
Class B ordinary shares |
Additional
Paid-in |
Accumulated | Total
Shareholders’ Equity |
|||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | (Deficit) | ||||||||||||||||||||||||||||
| Balance – January 1, 2026(1) | — | $ | — | — | $ | — | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||||
| Net loss | — | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||||||||
| Balance – March 31, 2026(1) | — | — | — | — | ( | ) | ( | ) | ||||||||||||||||||||||||||||
| Sale of Units in Initial Public Offering | — | — | — | — | — | |||||||||||||||||||||||||||||||
| Allocated value of transaction costs to right | — | — | — | — | — | — | ( | ) | — | ( | ) | |||||||||||||||||||||||||
| Sale of Private Placement Units | — | — | — | — | — | |||||||||||||||||||||||||||||||
| Issuance of representative shares | — | — | — | — | — | |||||||||||||||||||||||||||||||
| Share based compensation | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Forfeiture of Founder Shares | — | — | — | — | ( | ) | ( | ) | — | — | ||||||||||||||||||||||||||
| Accretion of Class A Ordinary Shares to redemption value | — | — | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||||||||
| Remeasurement of Class A Ordinary Shares subject to possible redemption | — | — | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Balance – June 30, 2026(2) | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||||||||||
| Remeasurement of Class A Ordinary Shares subject to possible redemption | — | — | — | — | — | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
| Balance – September 30, 2026 | $ | $ | $ | $ | — | $ | ( | ) | $ | ( | ) | |||||||||||||||||||||||||
FOR THE PERIOD FROM SEPTEMBER 10, 2025 (INCEPTION) THROUGH SEPTEMBER 30, 2025
| Class B Ordinary Shares |
Additional Paid-In |
Accumulated | Total Shareholder’s |
|||||||||||||||||
| Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||
| Balance – September 10, 2025 (inception) | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
| Issuance of Class B Ordinary Shares to Sponsor(1) | — | |||||||||||||||||||
| Net loss | — | — | — | ( | ) | ( | ) | |||||||||||||
| Balance – September 30, 2025 | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
| (1) | |
| (2) |
The accompanying notes are an integral part of these unaudited financial statements.
3
APERTURE AC
UNAUDITED STATEMENTS OF CASH FLOWS
| Nine Months Ended September 30, 2026 |
For the Period From September 10, 2025 (Inception) Through September 30, 2025 |
|||||||
| Cash Flows from Operating Activities: | ||||||||
| Net income (loss) | $ | $ | ( | ) | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| Interest earned on marketable securities held in Trust Account | ( | ) | — | |||||
| Payment of formation costs through IPO Promissory Note – related party | — | |||||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses | ( | ) | — | |||||
| Due from related party | — | |||||||
| Accounts payable | ||||||||
| Accrued expenses | ||||||||
| Net cash used in operating activities | ( | ) | — | |||||
| Cash Flows from Investing Activities: | ||||||||
| Investment in Trust Account | ( | ) | — | |||||
| Net cash used in investing activities | ( | ) | ||||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from sale of Public Units | — | |||||||
| Proceeds from sale of Private Placement Units | — | |||||||
| Payment of underwriter fees & commissions | ( | ) | — | |||||
| Proceeds from promissory note – related party | — | |||||||
| Payment of promissory note – related party | ( | ) | — | |||||
| Payment of offering costs | ( | ) | — | |||||
| Net cash provided by financing activities | — | |||||||
| Net change in cash | — | |||||||
| Cash – beginning of period | — | |||||||
| Cash – end of period | $ | $ | — | |||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||||||
| Accretion of Class A Ordinary Shares to redemption value | $ | $ | — | |||||
| Remeasurement of Class A Ordinary Shares to redemption value | $ | $ | — | |||||
| Deferred offering costs included in prepaid expenses | $ | $ | — | |||||
| Deferred offering costs included in accrued offering costs | $ | $ | — | |||||
| Offering costs associated with transfer of Founder Shares | $ | $ | — | |||||
| Forfeiture of Founder Shares | $ | $ | — | |||||
| Prepaid expenses paid via IPO Promissory Note – related party | $ | — | $ | |||||
| Offering costs paid by shareholders in exchange for issuance of Class B Ordinary Shares | $ | — | $ | |||||
| Offering costs paid via IPO Promissory Note – related party | $ | — | $ | |||||
The accompanying notes are an integral part of these unaudited financial statements.
4
APERTURE AC
NOTES TO UNAUDITED FINANCIAL STATEMENTS
SEPTEMBER 30, 2026
Note 1 — Organization and Business Operations
Aperture AC (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on September 10, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an early-stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies. The Company may pursue an acquisition opportunity in any business, industry or sector.
As of September 30, 2026, the Company had not yet commenced any operations. All activity for the period from
The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 17, 2025 (File No. 333-291583), was declared effective on May 14, 2026 (as amended, the “IPO Registration Statement”). On May 22, 2026, the Company consummated the initial public offering of
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of
Transaction costs amounted to $
Upon the closing of the Initial Public Offering, an aggregate of $
5
The Company will provide the Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of an initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable (other than excise or similar taxes)), divided by the number of then outstanding Public Shares, subject to the limitations. The amount in the Trust Account was $
The Company has only the duration of the Combination Period to complete the initial Business Combination. If the Company is unable to complete its initial Business Combination within the Combination Period, the Company will as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable (other than excise or similar taxes) and up to $
The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, dated May 20, 2026 (the “Letter Agreement”), pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (as defined in Note 6), Private Placement Shares and Public Shares in connection with (x) the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination and (y) a shareholder vote to approve an amendment to the Amended and Restated Articles to modify (1) the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $
Atlantic Business Combination
General Description of the Business Combination Agreement
On September 10, 2026, the Company entered into the Atlantic BCA with Atlantic, Merger Sub, the Sponsor, in the capacity as the representative for our shareholders (the “SPAC Representative”) and AHPC Holding LLC, in the capacity as representative for the stockholders of Atlantic (the “Seller Representative”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Atlantic BCA.
6
Pursuant to the Atlantic BCA and subject to the terms and conditions set forth therein, (i) on or prior to the consummation (the “Closing”, and the date and time of the Closing, the “Closing Date”), of the transactions contemplated by the Atlantic BCA, the Company will de-register from the Register of Companies of the Cayman Islands and transfer by way of continuation out of the Cayman Islands and into the State of Delaware so as to re-domicile as and become a Delaware corporation pursuant to Part 12 of the Companies Act (Revised) of the Cayman Islands and the applicable provisions of the General Corporation Law of the State of Delaware (the “Domestication”); and (ii) following the Domestication, Merger Sub will merge with and into Atlantic, with Atlantic continuing as the surviving entity (the “Merger”) and, as a result of which, shares of common stock of Atlantic, par value $
Consideration
The aggregate consideration to be delivered to the stockholders of Atlantic (the “Atlantic Stockholders”) as of the Effective Time will be a number of shares of SPAC Common Stock with an aggregate value equal to $
The Atlantic BCA also provides for an earnout of up to an additional
With respect to Share Price Milestones, during the Earnout Period, the Earnout Shares shall vest and be issued as follows:
| ● | if the volume weighted average price of SPAC Common Stock (the “VWAP”) over any three (3) consecutive calendar months (approximately sixty-three (63) trading days) equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Closing) (the “Tier I Share Price Milestone”), the Atlantic Stockholders shall be entitled to receive 1,500,000 Earnout Shares; and |
| ● | if the VWAP over any three (3) consecutive calendar months (approximately sixty-three (63) trading days) equals or exceeds $15.00 per share (as so adjusted) (the “Tier II Share Price Milestone”, and together with the Tier I Share Price Milestone, the “Share Price Milestones”), the Atlantic Stockholders shall be entitled to receive an additional 1,500,000 Earnout Shares. |
The Share Price Milestones will be tested monthly beginning with the third full calendar month after the Closing, and will be achieved only if, over the applicable measurement period, the public float of SPAC Common Stock held by our non-affiliates is at least
Representations and Warranties
The Atlantic BCA contains representations and warranties that are reasonably customary for similar transactions that are made by the parties as of the date of the Atlantic BCA, or other specified dates, solely for the benefit of certain of the parties to the Atlantic BCA, and in certain cases are subject to specified exceptions and materiality, Material Adverse Effect (as defined below), knowledge and other qualifications contained in the Atlantic BCA or in information provided pursuant to certain disclosure schedules to the Atlantic BCA. “Material Adverse Effect” means, with respect to any specified person or entity, any fact, event, occurrence, change or effect that has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (i) the business, assets, liabilities, results of operations or condition (financial or otherwise) of such person or entity and its subsidiaries, taken as a whole, or (ii) the ability of such person or entity or any of its subsidiaries on a timely basis to consummate the Atlantic Business Combination, subject to customary exceptions.
7
No Survival
The representations and warranties of the parties contained in the Atlantic BCA terminate as of, and do not survive, the Closing, and there are no indemnification rights for another party’s breach. The covenants and agreements of the parties contained in the Atlantic BCA do not survive the Closing, except those covenants and agreements to be performed after the Closing, which covenants and agreements will survive until fully performed.
Covenants of the Parties
Each party to the Atlantic BCA has agreed to use its commercially reasonable efforts, and to cooperate fully with one another, to consummate the Atlantic Business Combination. The Atlantic BCA also contains certain customary covenants by each of the parties that apply during the period between the signing of the Atlantic BCA and the earlier of the Closing or the termination of the Atlantic BCA (the “Interim Period”), including (i) the provision of access to the applicable party’s properties, books and personnel; (ii) the operation of the parties’ respective businesses in the ordinary course of business; (iii) the current and timely filing of our public filings; (iv) no insider trading; (v) notifications to the other parties of certain breaches, consent requirements and other matters; (vi) obtaining third-party and regulatory approvals; (vii) tax matters; (viii) further assurances; (ix) public announcements; (x) confidentiality; (xi) corporate governance and diligence matters, and (xii) other covenants. The Atlantic BCA also contains certain customary post-Closing covenants, including, without limitation, in regard to (1) tax matters; (2) the maintenance of books and records; and (3) the indemnification of directors and officers.
Additionally, both the Company and Atlantic agreed that they will not solicit or enter into a competing alternative transaction, in accordance with customary terms and provisions set forth in the Atlantic BCA.
The Company and Atlantic will, as promptly as practicable after the date of the Atlantic BCA, prepare and file with the SEC, a registration statement on Form S-4 in connection with the registration under the Securities Act of 1933, of the Company’s securities to be issued pursuant to the Atlantic BCA, and containing a proxy statement/prospectus for the solicitation of proxies from our shareholders to approve the Atlantic BCA, the Atlantic Business Combination and related matters at an extraordinary general meeting of our shareholders (the “SPAC Special Meeting”), and providing the Company’s public shareholders with an opportunity to request redemption of their public shares in connection with the Atlantic Business Combination (the “Redemption”), as required by the Company’s Amended and Restated Articles and the IPO Registration Statement.
As promptly as practicable after the Atlantic Registration Statement has become effective and distributed by the Company (and in all cases within ten days following such date), Atlantic will either (a) call a meeting of its stockholders (“Atlantic Special Meeting”) to obtain the Required Atlantic Stockholder Approval, and Atlantic shall use its reasonable best efforts to solicit from its stockholders proxies in favor of the Required Atlantic Stockholder Approval prior to such Atlantic Special Meeting, or (b) solicit from the Atlantic Stockholders a written consent in lieu of a meeting pursuant to Section 228(a) of the DGCL authorizing, approving and adopting the Atlantic BCA and the transactions contemplated thereby, including the Merger (such written consent, the “Atlantic Written Consent”), and Atlantic shall use its reasonable best efforts to obtain the Required Atlantic Stockholder Approval by delivery of the Atlantic Written Consent.
The parties shall take all action necessary so that, effective at the Closing, our post-Closing board of directors (the “Post-Closing Board”) will consist of five individuals, one will be designated by us (or the Sponsor), will be required to qualify as an independent director under the rules of the applicable Stock Exchange and will be reasonably acceptable to Atlantic, and four persons will be designated by Atlantic (at least two of whom shall be independent directors required to qualify as independent directors under the rules of the applicable Stock Exchange). In addition, at or prior to the Closing, we will enter into customary director indemnification agreements with each member of the Post-Closing Board.
During the Interim Period, us and Atlantic shall use the Company’s respective resources and commercially reasonable efforts to minimize redemptions by public shareholders in connection with the Closing, including by using commercially reasonable efforts to enter into written non-redemption agreements with public shareholders, on such terms as the Company and Atlantic shall mutually agree; provided that, in no event shall the Sponsor be required to transfer or forfeit any of its Founder Shares or any other of our securities in support of such efforts.
Conditions to Closing
The obligations of the parties to consummate the Atlantic Business Combination are subject to various conditions, including the following mutual conditions of the parties, unless waived: (i) the approval of the Atlantic BCA and the Atlantic Business Combination and related matters by the requisite vote of each of the Company’s shareholders and Atlantic’s stockholders; (ii) the expiration or termination of any waiting period applicable to the consummation of the Atlantic BCA under any antitrust laws; (iii) obtaining applicable regulatory approvals; (iv) no law or order preventing or prohibiting the Atlantic Business Combination; (v) appointment of the Post-Closing Board consistent with the requirements of the Atlantic BCA; (vi) the effectiveness of the Atlantic Registration Statement; (vii) the Domestication shall have been completed; (viii) the Amended SPAC Charter shall have been adopted in a form satisfactory to the Company and Atlantic; (ix) the SPAC Common Stock shall have been approved for listing on a Stock Exchange upon the Closing; and (x) the Company having adopted, on or prior to the Closing, an incentive plan substantially in the form attached to the Atlantic BCA.
8
In addition, unless waived by Atlantic, the obligations of Atlantic to consummate the Atlantic Business Combination are subject to the satisfaction of the following closing conditions, in addition to customary certificates and other closing deliveries: (i) the representations and warranties of the Company set forth in the Atlantic BCA and in any certificate delivered by or on behalf of the Company pursuant thereto being true and correct on and as of the date of the Atlantic BCA and on and as of the Closing Date as if made on the Closing Date; (ii) the Company and the SPAC Representative having performed in all material respects their respective obligations and complied in all material respects with the covenants and agreements under the Atlantic BCA required to be performed or complied with by them on or prior to the Closing Date; (iii) the Sponsor Support Agreement being in full force and effect in accordance with its terms as of the Closing; and (iv) the Company having delivered certain other documents as set forth in the Atlantic BCA.
Unless waived by the Company, our obligations to consummate the Atlantic Business Combination are subject to the satisfaction of the following closing conditions, in addition to customary certificates and other closing deliveries: (i) the representations and warranties of Atlantic set forth in the Atlantic BCA and in any certificate delivered by or on behalf of Atlantic pursuant thereto being true and correct on and as of the date of the Atlantic BCA and on and as of the Closing Date as if made on the Closing Date; (ii) Atlantic having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the Atlantic BCA required to be performed or complied with on or prior to the Closing Date; (iii) no Material Adverse Effect having occurred with respect to Atlantic since the date of the Atlantic BCA; (iv) the Company Support Agreement, the Non-Competition Agreements, each Lock-Up Agreement and the Insider Letter Amendment being in full force and effect as of the Closing; (v) Atlantic having delivered evidence reasonably acceptable to the Company that the contracts set forth on Schedule 6.3(e) have been terminated as of immediately prior to the Effective Time; (vi) the Company having received employment agreements, in each case effective as of the Closing, in form and substance reasonably acceptable to the Company; (vii) the Amended Registration Rights Agreement and the other applicable Ancillary Documents having been delivered to the Company; and (viii) the supplemental engagement letter in connection with financial reporting support having been delivered to the Company.
Termination
The Atlantic BCA may be terminated at any time prior to the Closing by either the Company or Atlantic if the Closing does not occur by May 22, 2027 (the “Outside Date”); provided that if the Company obtains, prior to the Outside Date, the approval of the Company’s shareholders for an extension (the “Extension”) of the deadline by which we must complete the Atlantic Business Combination, then the Outside Date shall automatically be extended for an additional period ending on the last date then in effect for the Company to consummate the Atlantic Business Combination pursuant to the Extension.
The Atlantic BCA may also be terminated under certain other customary and limited circumstances at any time prior to the Closing, including, among other reasons: (i) by mutual written consent of the Company and Atlantic; (ii) by written notice by either the Company or Atlantic to the other if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the Atlantic Business Combination, and such order or other action has become final and non-appealable; (iii) by Atlantic, following certain uncured breaches by the Company of our representations, warranties, covenants or agreements that would result in the failure of specified closing conditions; (iv) by the Company, following certain uncured breaches by Atlantic of its representations, warranties, covenants or agreements that would result in the failure of specified closing conditions; (v) by the Company, if there shall have been a Material Adverse Effect on the Target Companies following the date of the Atlantic BCA which is uncured and continuing; (vi) by either Atlantic or the Company if the SPAC Extraordinary General Meeting is held and the Required SPAC Shareholder Approval is not obtained; or (vii) by either Atlantic or the Company if the Atlantic Special Meeting is held and the Required Atlantic Stockholder Approval is not obtained, or if Atlantic solicits the Atlantic Written Consent and the Atlantic Stockholders holding a sufficient number of shares to constitute the Required Atlantic Stockholder Approval fail to deliver the Atlantic Written Consent within fifteen (15) Business Days following the date on which the Company first solicits such consent, subject to the limitations set forth in the Atlantic BCA.
If the Atlantic BCA is terminated, all further obligations of the parties under the Atlantic BCA (except for certain obligations related to public announcements, confidentiality, effect of termination, fees and expenses, trust account waiver, and customary miscellaneous provisions) will terminate, and no party to the Atlantic BCA will have any further liability to any other party thereto except for liability for fraud or for willful breach of the Atlantic BCA prior to such termination.
9
Fees and Expenses
All expenses incurred in connection with the Atlantic BCA and the transactions contemplated thereby prior to the date of the Atlantic BCA shall be paid by the party incurring such expenses; and from and after the date of the Atlantic BCA and prior to the Closing, all of the Company’s reasonable expenses incurred during such period in connection with the Atlantic BCA and the transactions contemplated thereby shall be the responsibility of Atlantic, regardless of whether the Closing occurs; provided that (i) if the Closing occurs, the combined public company will be responsible for, and will pay or reimburse the Company for, the unpaid expenses incurred by the Company from available funds, including cash remaining in the Trust Account after payment of the Redemption and the proceeds of any Transaction Financing, to the extent that the Company has first exhausted all of the Company’s available working capital maintained outside of the Trust Account, (ii) all fees, costs and expenses (including filing fees) under any applicable antitrust laws shall be shared equally between the parties, (iii) all fees, costs and expenses (including filing fees and printer costs) in connection with filing the Atlantic Registration Statement shall be shared equally between the parties, and (iv) all fees, costs and expenses (including filing fees) in connection with a stock exchange listing application shall be shared equally between the parties. Atlantic shall fund the Company’s expenses payable prior to the Closing by making loans to the Company under a single unsecured, non-interest bearing promissory note, in a form to be mutually agreed by the Company and Atlantic during the Interim Period, up to an aggregate outstanding principal amount of One Million Dollars ($1,000,000). As of September 30, 2026, no amounts were drawn under the agreement.
Trust Account Waiver
Each of Atlantic and Seller Representative agreed that it and its respective affiliates will not have any right, title, interest or claim of any kind in or to any monies in the Company’s trust account held for its public shareholders, and has agreed not to, and waived any right to, make any claim against the trust account (including any distributions therefrom).
Governing Law
The Atlantic BCA is governed by Delaware law, and the parties are subject to the exclusive jurisdiction of the Court of Chancery of the State of Delaware in and for New Castle County, Delaware or, if such court does not have jurisdiction, any federal court located in the State of Delaware or other Delaware state court (or, in each case, any appellate court thereof); provided that our internal corporate and constitutional matters prior to the Domestication shall be governed by the Laws of the Cayman Islands.
Related Agreements
Company Support Agreement
Simultaneously with the execution of the Atlantic BCA, AHPC Holding LLC (the “Atlantic Support Stockholder”), a significant stockholder of Atlantic holding capital stock of Atlantic sufficient to approve the adoption of Atlantic BCA and approve the Merger and the other transactions contemplated by the Atlantic BCA, entered into a voting and support agreement (the “Atlantic Support Agreement”), pursuant to which, among other things, the Atlantic Support Stockholder agreed to vote its shares of capital stock of Atlantic (the “Subject Stock”) in favor of the adoption of the Atlantic BCA, the ancillary documents, the approval of the Merger and the Atlantic Business Combination, and any amendments to the Atlantic’s organizational documents in connection therewith, subject to certain customary conditions. The Atlantic Support Stockholder also agreed to take certain other actions in support of the Atlantic BCA and the Atlantic Business Combination, including executing and delivering certain ancillary documents contemplated by the Atlantic BCA, and to refrain from taking actions that would adversely affect its ability to perform Atlantic Support Stockholder’s obligations under the Atlantic Support Agreement, and the Atlantic Support Stockholder unconditionally and irrevocably waived any and all pre-emption rights, rights of first offer, rights of first refusal, rights of participation, tag-along rights and all other similar rights that the Atlantic Support Stockholder may have in respect of the Atlantic Business Combination. The Atlantic Support Stockholder also agreed not to transfer its Subject Stock during the period from and including the date of the Atlantic Support Agreement and through and including the date on which the Atlantic Support Agreement is terminated, subject to certain customary exceptions.
Sponsor Support Agreement
Simultaneously with the execution of the Atlantic BCA, the Company, Atlantic and the Sponsor entered into a support agreement (the “Sponsor Support Agreement”), pursuant to which the Sponsor agreed, among other things, to (A) vote in favor of, take all actions necessary to consummate and otherwise support, the Atlantic Business Combination, and (B) waive any anti-dilution or similar protection with respect to the Founder Shares. In addition to the foregoing, the Sponsor Support Agreement provides that the Sponsor shall fully comply with the transfer restrictions set forth in the Insider Letter (as defined below) with respect to our securities held by the Sponsor, subject to certain limited exceptions set forth in the Insider Letter.
10
Lock-Up Agreements
Simultaneously with the execution of the Atlantic BCA, all stockholders of Atlantic, including officers or directors of Atlantic who own shares of Atlantic Common Stock, entered into a lock-up agreement (each, a “Lock-Up Agreement”) with the Company and the SPAC Representative, pursuant to which 70% of the shares of SPAC Common Stock received by each such Atlantic Stockholder as Merger Consideration will be subject to transfer restrictions for a period commencing from the Closing and ending on the date that is six months after the Closing Date (subject to early release on the earlier of (x) the date on which the closing price of the SPAC Common Stock equals or exceeds $15.00 for any 20 trading days within any 30 trading day period after the Closing and (y) the date after the Closing on which we consummate a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of its stockholders having the right to exchange their shares for cash, securities or other property), subject to certain customary transfer exceptions.
Non-Competition and Non-Solicitation Agreement
Simultaneously with the execution and delivery of the Atlantic BCA, each of Jacqueline Jiang and Tian Sheng Tan (each, a “Subject Party”) entered into a Non-Competition and Non-Solicitation Agreement (each, a “Non-Competition Agreement”) in favor of the Company and Atlantic (the “Covered Parties”), pursuant to which each Subject Party agreed for a period of three years after the Closing not to compete with the Covered Parties and not to solicit the employees, customers and suppliers of the Covered Parties, subject to the limitations set forth in the applicable Non-Competition Agreement.
Insider Letter Amendment
Simultaneously with the execution of the Atlantic BCA, the Company, the Sponsor, the Company’s directors and officers and IB Capital, entered into an amendment (the “Insider Letter Amendment”) to the Letter Agreement. The Insider Letter Amendment provides that, effective upon the Closing, the transfer restrictions set forth in the Letter Agreement will not apply to 30% of each of the Founder Shares, Private Placement Shares and shares issued in exchange for the Private Placement Rights in connection with the Closing, in each case held by the Sponsor and each Insider.
See Form 8-K filed with the SEC on September 16, 2026 for further discussion on the Business Combination.
Liquidity, Capital Resources and Going Concern
As of September 30, 2026, and December 31, 2025, the Company had $
The Company has until May 22, 2027 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution.
Further, the Company expects to incur significant costs in pursuit of a Business Combination. Management’s plans to address the Company’s liquidity shortfall include utilizing the expense-funding arrangements under the Business Combination Agreement with Atlantic, seeking additional Working Capital Loans as necessary, and completing the proposed Business Combination within the Combination Period. The agreement with Atlantic provides for Atlantic to fund eligible expenses through an unsecured, non-interest-bearing promissory note with an aggregate outstanding principal limit of $
In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,”, Management has determined that the Company does not have sufficient liquidity to meet its current obligations, which is considered to be one year from the date of the issuance of the accompanying unaudited financial statements. In addition, Management has determined that if the Company is unable to complete a Business Combination within the Combination Period, then the Board would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. The accompanying unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.
11
Risks and Uncertainties
The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, and tariff on imports from foreign countries could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.
Note 2 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the accompanying unaudited financial statements do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.
In the opinion of Management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited financial statements should be read in conjunction with the IPO Registration Statement, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on May 29, 2026. The interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026, or for any future periods.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the accompanying unaudited financial statements with another public company that is neither an (i) emerging growth company nor (ii) emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
12
Use of Estimates
The preparation of the accompanying unaudited financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $
Marketable Securities Held in Trust Account
At September 30, 2026, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Fair values of these marketable securities are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets. As of September 30, 2026 and December 31, 2025, the Company reported
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limitation of $
Deferred Offering Costs
The Company complies with the requirements of the FASB ASC Topic 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are directly related to the Initial Public Offering. FASB ASC Topic 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate Initial Public Offering proceeds from the Units between Public Shares and Public Rights, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Public Rights and then to the Public Shares. Deferred offering costs allocated to the Public Shares subject to possible redemption were charged to temporary equity. Offering costs allocated to the Public Rights were charged to shareholders’ deficit. After Management’s evaluation, the Public Rights included in the Public Units were accounted for as equity classified financial instruments.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), approximates the carrying amounts represented in the accompanying unaudited balance sheets, primarily due to their short-term nature.
13
The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines “fair value” as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
| ● | “Level 1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| ● | “Level 2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and | |
| ● | “Level 3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the accompanying unaudited statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the accompanying unaudited balance sheets as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Over-Allotment Option is deemed to be a freestanding financial instrument indexed on the shares subject to redemption and will be accounted for as a liability pursuant to ASC 480 for the underwriters’ remaining over-allotment option until fully exercised or upon the expiration of the 30-day option exercise period. On May 22, 2026, the Over-Allotment Option was partially exercised as part of the closing of the Initial Public Offering, and the Underwriters waived the remainder of their Over-Allotment Option. As such,
Net Income Per Ordinary Share
The Company has two classes of shares, non-redeemable Class A Ordinary Shares and Class B Ordinary Shares and redeemable Class A Ordinary Shares.
The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. The unaudited condensed statements of operations include a presentation of income per redeemable Class A Ordinary Shares and income per non-redeemable Class A Ordinary Shares and Class B Ordinary Shares following the two-class method of income per Ordinary Shares. In order to determine the net income attributable to both the redeemable Class A Ordinary Shares and non-redeemable Ordinary Shares, the Company first considered the total income allocable to both classes of Ordinary Shares. This is calculated using the total net income less any dividends paid. For purposes of calculating net income per share, income earned on marketable securities and cash held in Trust Account is economically attributable to redeemable Class A Ordinary Shares. As such, any remeasurement of the redeemable Class A Ordinary Shares as a result of income earned on marketable securities and cash held in Trust Account was treated as dividends paid to the Public Shareholders and is reflected as an adjustment through accretion applicable to remeasurement of Class A Ordinary Shares to redemption value. Subsequent to calculating the total income allocable to both classes of ordinary shares, the Company split the amount to be allocated using the weighted average shares outstanding ratio for the redeemable Class A ordinary shares and for the non-redeemable ordinary shares for the three and nine months ended September 30, 2026.
14
The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per Ordinary Share for each class of Ordinary Shares for the three and nine months ended September 30, 2026:
| Basic | ||||||||
| For the | For the | |||||||
| Three Months Ended | Nine Months Ended | |||||||
| September 30, 2026 | September 30, 2026 | |||||||
| Class A Ordinary Shares subject to possible redemption | ||||||||
| Numerator: | ||||||||
| Net income attributable to Class A Ordinary Shares subject to possible redemption | $ | $ | ||||||
| Denominator: | ||||||||
| Basic weighted average shares outstanding, Class A Ordinary Shares subject to possible redemption | ||||||||
| Basic net income per share, Class A Ordinary Shares subject to possible redemption | $ | $ | ||||||
| Diluted | ||||||||
| For the | For the | |||||||
| Three Months Ended | Nine Months Ended | |||||||
| September 30, 2026 | September 30, 2026 | |||||||
| Class A Ordinary Shares subject to possible redemption | ||||||||
| Numerator: | ||||||||
| Net income attributable to Class A Ordinary Shares subject to possible redemption | $ | $ | ||||||
| Denominator: | ||||||||
| Diluted weighted average shares outstanding, Class A Ordinary Shares subject to possible redemption | ||||||||
| Diluted net income per share, Class A Ordinary Shares subject to possible redemption | $ | $ | ||||||
| Basic | ||||||||
| For the | For the | |||||||
| Three Months Ended | Nine Months Ended | |||||||
| September 30, 2026 | September 30, 2026 | |||||||
| Non-Redeemable Class A Ordinary Shares | ||||||||
| Numerator: | ||||||||
| Net income attributable to Non-Redeemable Class A Ordinary Shares | $ | $ | ||||||
| Denominator: | ||||||||
| Basic weighted average shares outstanding, Non-Redeemable Class A Ordinary Shares | ||||||||
| Basic net income per share, Non-Redeemable Class A Ordinary Shares | $ | $ | ||||||
| Diluted | ||||||||
| For the | For the | |||||||
| Three Months Ended | Nine Months Ended | |||||||
| September 30, 2026 | September 30, 2026 | |||||||
| Non-Redeemable Class A Ordinary Shares | ||||||||
| Numerator: | ||||||||
| Net income attributable to Non-Redeemable Class A Ordinary Shares | $ | $ | ||||||
| Denominator: | ||||||||
| Diluted weighted average shares outstanding, Non-Redeemable Class A Ordinary Shares | ||||||||
| Diluted net income per share, Non-Redeemable Class A Ordinary Shares | $ | $ | ||||||
15
| Basic | ||||||||
| For the | For the | |||||||
| Three Months Ended | Nine Months Ended | |||||||
| September 30, 2026 | September 30, 2026 | |||||||
| Non-Redeemable Class B Ordinary Shares | ||||||||
| Numerator: | ||||||||
| Net income attributable to Non-Redeemable Class B Ordinary Shares | $ | $ | ||||||
| Denominator: | ||||||||
| Basic weighted average shares outstanding, Non-Redeemable Class B Ordinary Shares | ||||||||
| Basic net income per share, Non-Redeemable Class B Ordinary Shares | $ | $ | ||||||
| Diluted | ||||||||
| For the | For the | |||||||
| Three Months Ended | Nine Months Ended | |||||||
| September 30, 2026 | September 30, 2026 | |||||||
| Non-Redeemable Class B Ordinary Shares | ||||||||
| Numerator: | ||||||||
| Net income attributable to Non-Redeemable Class B Ordinary Shares | $ | $ | ||||||
| Denominator: | ||||||||
| Diluted weighted average shares outstanding, Non-Redeemable Class B Ordinary Shares | ||||||||
| Diluted net income per share, Non-Redeemable Class B Ordinary Shares | $ | $ | ||||||
For the period from September 10, 2025 (inception) through September 30, 2025, there were no Class A Redeemable shares outstanding or Class A Non-redeemable shares outstanding. As such, net loss per Class B Non-redeemable shares was calculated by dividing net loss of $
Income Taxes
The Company accounts for income taxes under FASB ASC Topic 740, “Income Taxes,” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. Management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBA”). ASC 740, “Income Taxes”, requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the impact of the new law. However, none of the tax provisions are expected to have a significant impact on the Company’s financial statements.
16
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary Shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable Ordinary Shares (including Ordinary Shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, Ordinary Shares will be classified as shareholders’ equity. In accordance with ASC 480-10-S99, the Company classifies the Class A Ordinary Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the
| Gross proceeds from Initial Public Offering | $ | |||
| Less: | ||||
| Proceeds allocated to Public Rights | ( | ) | ||
| Offering costs allocated to Class A Ordinary Shares subject to possible redemption | ( | ) | ||
| Offering costs allocated to Public Rights | ( | ) | ||
| Plus: | ||||
| Accretion of Class A Ordinary Shares subject to possible redemption | ||||
| Remeasurement of Class A Ordinary Shares to redemption value | ||||
| Class A Ordinary Shares subject to possible redemption at September 30, 2026 | $ |
Share Rights
The Company accounts for the Rights issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in ASC 815. Accordingly, the Company evaluated and classified the Rights as equity classified financial instruments, at its fair value, at the closing of the Initial Public Offering.
Share-Based Compensation
The Company accounts for share awards in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” which requires that all equity awards be accounted for at their “fair value.” Fair value is measured on the grant date and is equal to the underlying value of the share. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. As of September 30 2026 and December 31, 2025, Sponsor membership interests corresponding to
Recent Accounting Standards
In November 2023, the FASB issued ASU Topic 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The amendments in ASU 2023-07 require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by FASB ASC Topic 280, “Segment Reporting,” (“ASC 280”) in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in ASU 2023-07 and existing segment disclosures in ASC 280. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on September 10, 2025, the date of its incorporation.
17
In December 2023, the FASB issued ASU Topic 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”), which enhances the transparency and usefulness of income tax disclosures. ASU 2023-09 will be effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company adopted ASU 2023-09 on September 10, 2025, the date of its incorporation. Adoption of ASU 2023-09 did not impact the Company’s financial position, results of operations or cash flows.
Note 3 — Initial Public Offering
In the Initial Public Offering on May 22, 2026, the Company sold
Note 4 — Private Placement
Simultaneously with the consummation of the Initial Public Offering, the Sponsor and the Underwriters purchased an aggregate of
Note 5 — Segment Information
ASC Topic 280, Segment Reporting, establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.
ASC 280 establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.
The CODM reviews total operating expenses to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Combination Period. The CODM also reviews total operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Total operating expenses and income generated on the Trust Account, as reported on the accompanying unaudited statement of operations, are the significant segment information provided to the CODM on a regular basis. All other segment items included in net income or loss are reported on the accompanying unaudited statement of operations and described within their respective disclosures.
| Three Months Ended September 30, 2026 | Nine Months Ended September 30, 2026 | For the Period From September 10, 2025 (Inception) Through September 30, 2025 | ||||||||||
| Formation, general and administrative expenses | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||
| Legal and accounting expenses | ( | ) | ( | ) | — | |||||||
| Insurance expense | ( | ) | ( | ) | — | |||||||
| Listing fees | ( | ) | ( | ) | — | |||||||
| Administrative services fee – related party | ( | ) | ( | ) | — | |||||||
| Interest earned on bank account | — | |||||||||||
| Interest earned on cash and marketable securities held in Trust Account | — | |||||||||||
| Net income (loss) | $ | $ | $ | ( | ) | |||||||
The CODM additionally reviews liquidity metrics reported on the balance sheet as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in total assets.
18
The CODM reviews cash to monitor the Company’s liquidity to determine the Company’s ability to meet working capital needs and cash management strategies. The CODM also reviews cash and marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement. The CODM reviews income generated on the amounts held in the Trust Account to forecast the amount of capital it will have for a Business Combination.
| As of September 30, | As of December 31, | |||||||
| 2026 | 2025 | |||||||
| Cash | $ | $ | ||||||
| Marketable securities Held in Trust Account | $ | $ | — | |||||
Note 6 — Related Party Transactions
Founder Shares
On September 30, 2025, the Company issued
On April 28, 2026, April 30, 2026, May 5, 2026, and May 12, 2026, the Sponsor granted membership interests to each of three directors of the Company, the Chief Financial Officer (“CFO”), and the CEO. The membership interests received in the Sponsor correspond to an aggregate of
The sale of the membership interests to the Company’s directors is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the
The Founder Shares are identical to the Public Shares included in the Public Units, except that the Founder Shares automatically convert into Public Shares at the time of the initial Business Combination (with such conversion taking place immediately prior to, simultaneously with, or immediately following the time of the initial Business Combination. The Sponsor agreed to forfeit up to an aggregate of
Pursuant to the Letter Agreement, the Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $
19
IPO Promissory Note — Related Party
On September 30, 2025, the Company and the Sponsor entered into a loan agreement, whereby the Sponsor agreed to loan the Company an aggregate of up to $
Due From Related Party
The Company has a $
Administrative Services Agreement
The Company entered into an agreement, commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of up to $
Working Capital Loans
In addition, in order to finance transaction costs in connection with its initial Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. If the Sponsor makes any Working Capital Loans, up to $
Note 7 — Commitments and Contingencies
Registration Rights Agreement
The holders of the (i) Founder Shares, (ii) Private Placement Units (and the securities comprising such Private Placement Units), (iii) units that may be issued upon conversion of Working Capital Loans (and the securities comprising such units) and (iv) Representative Shares have registration rights to require us to register a sale of any of the Company’s securities held by them and any other securities of the company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement, dated May 20, 2026 (the “Registration Rights Agreement”) . The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to completion of the initial Business Combination. Notwithstanding anything to the contrary, the Underwriters may only make a demand on one occasion and only during the five-year period beginning on the effective date of the IPO Registration Statement. In addition, the Underwriters may participate in a “piggyback” registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Underwriters had a
The Underwriters were paid a cash underwriting discount of $
20
Representative Shares
The Company issued
The Representative Shares have been deemed compensation by the Financial Industry Regulatory Authority (“FINRA”) and are therefore subject to a lock-up for a period of
Note 8 — Shareholders’ Deficit
Preference Shares — The Company is authorized to issue a total of
Class A Ordinary Shares — The Company is authorized to issue a total of
Class B Ordinary Shares — The Company is authorized to issue a total of
The Founder Shares will automatically convert into Class A Ordinary Shares at the time of a Business Combination or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional Class A Ordinary Shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which the Class B Ordinary Shares will convert into Class A Ordinary Shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B Ordinary Shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Ordinary Shares issuable upon conversion of all Class B Ordinary Shares will equal, in the aggregate, on an as-converted basis,
Except as set forth below, holders of the Ordinary Shares are entitled to one vote for each share held on all matters to be voted on by shareholders, voting together as a single class. Unless specified in the Amended and Restated Articles or as required by the Companies Act (As Revised) of the Cayman Islands or stock exchange rules, an ordinary resolution under Cayman Islands law and the Amended and Restated Articles, which requires the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by the shareholders, voting together as a single class. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the Amended and Restated Articles, such actions include amending the Amended and Restated Articles and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following the initial Business Combination, the holders of more than
21
Rights — Except in cases where the Company is not the surviving company in a Business Combination,
Note 9 — Fair Value Measurements
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date.
The following table presents information about the Company’s recurring fair value measurements as of September 30, 2026, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| Level | September 30, 2026 | ||||||
| Assets: | |||||||
| Marketable securities held in Trust Account | 1 | $ | |||||
The following table presents information about the Company’s non-recurring fair value measurements as of May 22, 2026, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| Level | May 22, 2026 | ||||||
| Equity: | |||||||
| Fair value of Public Rights for Class A ordinary shares subject to possible redemption allocation | 3 | $ | |||||
| Fair value of Representative Shares issued at Initial Public Offering | 3 | $ | |||||
The Public Rights were valued using a blended approach incorporating both a market-based method and an implied-value (income approach) framework derived from observable trading data. The valuation was based on a peer group selection of comparable special purpose acquisition companies who were pre-business combination, included similar rights coverage as part of their units that were publicly trading, and had consummated their initial public offerings within six months of the valuation date. Utilizing this criteria, a right price of $
The fair value of the Class B Ordinary Shares is $
| April 28, 2026 | ||||
| Underlying stock price | $ | |||
| Estimated volatility | % | |||
| Risk-free rate | % | |||
| Time to expiration (years) | ||||
| Downside protection | $ | |||
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after September 30, 2026, the balance sheet date, up to the date the accompanying unaudited financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustments or disclosure in the accompanying unaudited financial statements.
22
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, possible Business Combinations and the financing thereof, and related matters, and the plans and objectives of Management for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. When used in this Report, words such as “may,” “should,” “could,” “would,” “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. We have based these forward-looking statements on our Management’s current expectations and projections about future events, as well as assumptions made by, and information currently available to our Management. Actual results could differ materially from those contemplated by such forward-looking statements as a result of certain factors detailed in our filings with the SEC, including herein. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited financial statements and the notes thereto included in this Report under Item 1. “Financial Statements”.
Overview
We are a blank check company incorporated in the Cayman Islands on September 10, 2025 for the purpose of effecting a Business Combination. Our Sponsor is Aperture Sponsor LLC.
Although we are not limited in our search for target businesses to a particular industry or sector for the purpose of consummating the Business Combination, we are focusing our search on lower middle market companies building essential digital asset infrastructure. We are an early stage and emerging growth company and, as such, we are subject to all of the risks associated with early stage and emerging growth companies. We expect to incur significant costs in the pursuit of our acquisition plans. There can be no assurance that our plans to complete a Business Combination will be successful.
Our IPO Registration Statement became effective on May 14, 2026. On May 22, 2026, we consummated our Initial Public Offering of 10,200,000 Public Units, including 1,200,000 Option Units issued pursuant to the partial exercise of the Over-Allotment Option. Each Public Unit consists of one Public Share and one Public Right. The Public Units were sold at a price of $10.00 per Public Unit, generating gross proceeds to us of $102,000,000.
Simultaneously with the closing of the Initial Public Offering and pursuant to the Private Placement Units Purchase Agreements, we completed the sale of an aggregate of 311,000 Private Placement Units to the Sponsor and the Underwriters in the Private Placement at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to us of $3,110,000. Of those 311,000 Private Placement Units, the Sponsor purchased 223,000 Private Placement Units and the Underwriters purchased 88,000 Private Placement Units. The Private Placement Units (and underlying securities) are identical to the Public Units (and underlying securities), except as otherwise disclosed in the IPO Registration Statement.
Following the closing of the Initial Public Offering and Private Placement, the amount of $102,255,000 from the net proceeds of the Initial Public Offering and the Private Placement was initially placed in the Trust Account located in the United States with Continental acting as trustee. Pursuant to the Trust Agreement, the Trust Account may be invested only (i) in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act with a maturity of 185 days or less, (ii) in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, (iii) as uninvested cash or (iv) in interest or non-interest bearing demand deposit accounts at a U.S. chartered commercial bank with consolidated assets of $100 billion or more selected by Continental that is reasonably satisfactory to us, until the earlier of: (x) the completion of the Business Combination and (y) the distribution of the Trust Account, as described below.
We have until May 22, 2027 (12 months from the closing of the Initial Public Offering), or until such (x) earlier date as our Board may approve or (y) later date as our shareholders may approve, pursuant to the Amended and Restated Articles, to consummate the Business Combination. If we are unable to complete the Business Combination by the end of the Combination Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes, if any, divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board, dissolve and liquidate, subject, in each case, to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
23
We may seek to extend the Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles. Any such amendment would require the approval of our shareholders, and our Public Shareholders will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete their initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to a suspension of trading and delisting from Nasdaq. Our Sponsor may also, in its discretion, consider selling its interest in our Company to another sponsor entity, which may result in a change to our Management Team.
Recent Developments
Atlantic Business Combination
General Description of the Business Combination Agreement
On September 10, 2026, we entered into the Atlantic BCA with Atlantic, Merger Sub, the Sponsor, in the capacity as the representative for our shareholders (the “SPAC Representative”) and AHPC Holding LLC, in the capacity as representative for the stockholders of Atlantic (the “Seller Representative”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Atlantic BCA.
Pursuant to the Atlantic BCA and subject to the terms and conditions set forth therein, (i) on or prior to the consummation (the “Closing”, and the date and time of the Closing, the “Closing Date”), of the transactions contemplated by the Atlantic BCA, we will de-register from the Register of Companies of the Cayman Islands and transfer by way of continuation out of the Cayman Islands and into the State of Delaware so as to re-domicile as and become a Delaware corporation pursuant to Part 12 of the Companies Act (Revised) of the Cayman Islands and the applicable provisions of the General Corporation Law of the State of Delaware (the “Domestication”); and (ii) following the Domestication, Merger Sub will merge with and into Atlantic, with Atlantic continuing as the surviving entity (the “Merger”) and, as a result of which, shares of common stock of Atlantic, par value $0.0001 per share (the “Atlantic Common Stock”) issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”), other than certain excluded securities and dissenting shares, shall no longer be outstanding and shall automatically be cancelled and cease to exist in exchange for the right to receive a number of shares of our common stock, par value $0.0001 per share (the “SPAC Common Stock”) with an aggregate value equal to One Hundred and Fifty Million U.S. Dollars ($150,000,000), with each share valued at $10.00. As a result of the Merger and the other transactions contemplated by the Atlantic BCA, Atlantic will become our wholly owned subsidiary, all upon the terms and subject to the conditions set forth in the Atlantic BCA.
Consideration
The aggregate consideration to be delivered to the stockholders of Atlantic (the “Atlantic Stockholders”) as of the Effective Time will be a number of shares of SPAC Common Stock with an aggregate value equal to $150,000,000 (the “Merger Consideration”), with each share valued at $10.00. Each holder of Atlantic Common Stock is entitled to receive its pro rata share of the Merger Consideration.
The Atlantic BCA also provides for an earnout of up to an additional 6,000,000 shares of SPAC Common Stock (the “Earnout Shares”) to the Atlantic Stockholders as additional consideration, based on the achievement of the Share Price Milestones or the Lease Milestone (as defined below), as applicable, during the period commencing on the Closing Date and ending on the fifth anniversary thereof (the “Earnout Period”). If, at any time from the date of the Atlantic BCA through the expiration of the Earnout Period, Atlantic (or, following the Closing, us) executes a binding, arm’s-length lease for the entire Phase I capacity (five megawatt) of Atlantic’s data center, with a tenant that is not an affiliate of Atlantic and whose obligations thereunder are not funded or guaranteed by Atlantic or any of its stockholders, and such lease contains an initial non-cancelable term of at least seven (7) years (the “Lease Milestone”), the Atlantic Stockholders shall be entitled to receive an aggregate of 3,000,000 Earnout Shares. If the Lease Milestone is achieved prior to the Closing, the corresponding Earnout Shares shall be issued at the Closing together with the base Merger Consideration.
24
With respect to Share Price Milestones, during the Earnout Period, the Earnout Shares shall vest and be issued as follows:
| ● | if the volume weighted average price of SPAC Common Stock (the “VWAP”) over any three (3) consecutive calendar months (approximately sixty-three (63) trading days) equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Closing) (the “Tier I Share Price Milestone”), the Atlantic Stockholders shall be entitled to receive 1,500,000 Earnout Shares; and |
| ● | if the VWAP over any three (3) consecutive calendar months (approximately sixty-three (63) trading days) equals or exceeds $15.00 per share (as so adjusted) (the “Tier II Share Price Milestone”, and together with the Tier I Share Price Milestone, the “Share Price Milestones”), the Atlantic Stockholders shall be entitled to receive an additional 1,500,000 Earnout Shares. |
The Share Price Milestones will be tested monthly beginning with the third full calendar month after the Closing, and will be achieved only if, over the applicable measurement period, the public float of SPAC Common Stock held by our non-affiliates is at least 2,000,000 shares and the average daily trading volume of SPAC Common Stock is at least 50,000 shares (excluding, in each case, trades by the pre-Closing Atlantic Stockholders and their affiliates). Achievement of the Tier II Share Price Milestone will be deemed to include achievement of the Tier I Share Price Milestone if not previously achieved. If a Change of Control (as defined in the Atlantic BCA) occurs during the Earnout Period, any Share Price Milestone not previously achieved will be deemed achieved if the per-share consideration payable to holders of SPAC Common Stock in such transaction equals or exceeds the applicable Share Price Milestone threshold. Once issued, Earnout Shares are not subject to clawback or forfeiture.
Representations and Warranties
The Atlantic BCA contains representations and warranties that are reasonably customary for similar transactions that are made by the parties as of the date of the Atlantic BCA, or other specified dates, solely for the benefit of certain of the parties to the Atlantic BCA, and in certain cases are subject to specified exceptions and materiality, Material Adverse Effect (as defined below), knowledge and other qualifications contained in the Atlantic BCA or in information provided pursuant to certain disclosure schedules to the Atlantic BCA. “Material Adverse Effect” means, with respect to any specified person or entity, any fact, event, occurrence, change or effect that has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (i) the business, assets, liabilities, results of operations or condition (financial or otherwise) of such person or entity and its subsidiaries, taken as a whole, or (ii) the ability of such person or entity or any of its subsidiaries on a timely basis to consummate the Atlantic Business Combination, subject to customary exceptions.
No Survival
The representations and warranties of the parties contained in the Atlantic BCA terminate as of, and do not survive, the Closing, and there are no indemnification rights for another party’s breach. The covenants and agreements of the parties contained in the Atlantic BCA do not survive the Closing, except those covenants and agreements to be performed after the Closing, which covenants and agreements will survive until fully performed.
Covenants of the Parties
Each party to the Atlantic BCA has agreed to use its commercially reasonable efforts, and to cooperate fully with one another, to consummate the Atlantic Business Combination. The Atlantic BCA also contains certain customary covenants by each of the parties that apply during the period between the signing of the Atlantic BCA and the earlier of the Closing or the termination of the Atlantic BCA (the “Interim Period”), including (i) the provision of access to the applicable party’s properties, books and personnel; (ii) the operation of the parties’ respective businesses in the ordinary course of business; (iii) the current and timely filing of our public filings; (iv) no insider trading; (v) notifications to the other parties of certain breaches, consent requirements and other matters; (vi) obtaining third-party and regulatory approvals; (vii) tax matters; (viii) further assurances; (ix) public announcements; (x) confidentiality; (xi) corporate governance and diligence matters, and (xii) other covenants. The Atlantic BCA also contains certain customary post-Closing covenants, including, without limitation, in regard to (1) tax matters; (2) the maintenance of books and records; and (3) the indemnification of directors and officers.
Additionally, both us and Atlantic agreed that they will not solicit or enter into a competing alternative transaction, in accordance with customary terms and provisions set forth in the Atlantic BCA.
We and Atlantic will, as promptly as practicable after the date of the Atlantic BCA, prepare and file with the SEC, a registration statement on Form S-4 in connection with the registration under the Securities Act of 1933, of our securities to be issued pursuant to the Atlantic BCA, and containing a proxy statement/prospectus for the solicitation of proxies from our shareholders to approve the Atlantic BCA, the Atlantic Business Combination and related matters at an extraordinary general meeting of our shareholders (the “SPAC Special Meeting”), and providing our public shareholders with an opportunity to request redemption of their public shares in connection with the Atlantic Business Combination (the “Redemption”), as required by our Amended and Restated Articles and the IPO Registration Statement.
25
As promptly as practicable after the Atlantic Registration Statement has become effective and distributed by us (and in all cases within ten days following such date), Atlantic will either (a) call a meeting of its stockholders (“Atlantic Special Meeting”) to obtain the Required Atlantic Stockholder Approval, and Atlantic shall use its reasonable best efforts to solicit from its stockholders proxies in favor of the Required Atlantic Stockholder Approval prior to such Atlantic Special Meeting, or (b) solicit from the Atlantic Stockholders a written consent in lieu of a meeting pursuant to Section 228(a) of the DGCL authorizing, approving and adopting the Atlantic BCA and the transactions contemplated thereby, including the Merger (such written consent, the “Atlantic Written Consent”), and Atlantic shall use its reasonable best efforts to obtain the Required Atlantic Stockholder Approval by delivery of the Atlantic Written Consent.
The parties shall take all action necessary so that, effective at the Closing, our post-Closing board of directors (the “Post-Closing Board”) will consist of five individuals, one will be designated by us (or the Sponsor), will be required to qualify as an independent director under the rules of the applicable Stock Exchange and will be reasonably acceptable to Atlantic, and four persons will be designated by Atlantic (at least two of whom shall be independent directors required to qualify as independent directors under the rules of the applicable Stock Exchange). In addition, at or prior to the Closing, we will enter into customary director indemnification agreements with each member of the Post-Closing Board.
During the Interim Period, us and Atlantic shall use our respective resources and commercially reasonable efforts to minimize redemptions by public shareholders in connection with the Closing, including by using commercially reasonable efforts to enter into written non-redemption agreements with public shareholders, on such terms as us and Atlantic shall mutually agree; provided that, in no event shall the Sponsor be required to transfer or forfeit any of its Founder Shares or any other of our securities in support of such efforts.
Conditions to Closing
The obligations of the parties to consummate the Atlantic Business Combination are subject to various conditions, including the following mutual conditions of the parties, unless waived: (i) the approval of the Atlantic BCA and the Atlantic Business Combination and related matters by the requisite vote of each of our shareholders and Atlantic’s stockholders; (ii) the expiration or termination of any waiting period applicable to the consummation of the Atlantic BCA under any antitrust laws; (iii) obtaining applicable regulatory approvals; (iv) no law or order preventing or prohibiting the Atlantic Business Combination; (v) appointment of the Post-Closing Board consistent with the requirements of the Atlantic BCA; (vi) the effectiveness of the Atlantic Registration Statement; (vii) the Domestication shall have been completed; (viii) the Amended SPAC Charter shall have been adopted in a form satisfactory to us and Atlantic; (ix) the SPAC Common Stock shall have been approved for listing on a Stock Exchange upon the Closing; and (x) us having adopted, on or prior to the Closing, an incentive plan substantially in the form attached to the Atlantic BCA.
In addition, unless waived by Atlantic, the obligations of Atlantic to consummate the Atlantic Business Combination are subject to the satisfaction of the following closing conditions, in addition to customary certificates and other closing deliveries: (i) the representations and warranties of us set forth in the Atlantic BCA and in any certificate delivered by or on behalf of us pursuant thereto being true and correct on and as of the date of the Atlantic BCA and on and as of the Closing Date as if made on the Closing Date; (ii) us and the SPAC Representative having performed in all material respects their respective obligations and complied in all material respects with the covenants and agreements under the Atlantic BCA required to be performed or complied with by them on or prior to the Closing Date; (iii) the Sponsor Support Agreement being in full force and effect in accordance with its terms as of the Closing; and (iv) us having delivered certain other documents as set forth in the Atlantic BCA.
Unless waived by us, our obligations to consummate the Atlantic Business Combination are subject to the satisfaction of the following closing conditions, in addition to customary certificates and other closing deliveries: (i) the representations and warranties of Atlantic set forth in the Atlantic BCA and in any certificate delivered by or on behalf of Atlantic pursuant thereto being true and correct on and as of the date of the Atlantic BCA and on and as of the Closing Date as if made on the Closing Date; (ii) Atlantic having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the Atlantic BCA required to be performed or complied with on or prior to the Closing Date; (iii) no Material Adverse Effect having occurred with respect to Atlantic since the date of the Atlantic BCA; (iv) the Company Support Agreement, the Non-Competition Agreements, each Lock-Up Agreement and the Insider Letter Amendment being in full force and effect as of the Closing; (v) Atlantic having delivered evidence reasonably acceptable to us that the contracts set forth on Schedule 6.3(e) have been terminated as of immediately prior to the Effective Time; (vi) us having received employment agreements, in each case effective as of the Closing, in form and substance reasonably acceptable to us; (vii) the Amended Registration Rights Agreement and the other applicable Ancillary Documents having been delivered to us; and (viii) the supplemental engagement letter in connection with financial reporting support having been delivered to us.
26
Termination
The Atlantic BCA may be terminated at any time prior to the Closing by either us or Atlantic if the Closing does not occur by May 22, 2027 (the “Outside Date”); provided that if we obtain, prior to the Outside Date, the approval of our shareholders for an extension (the “Extension”) of the deadline by which we must complete the Atlantic Business Combination, then the Outside Date shall automatically be extended for an additional period ending on the last date then in effect for us to consummate the Atlantic Business Combination pursuant to the Extension.
The Atlantic BCA may also be terminated under certain other customary and limited circumstances at any time prior to the Closing, including, among other reasons: (i) by mutual written consent of us and Atlantic; (ii) by written notice by either us or Atlantic to the other if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the Atlantic Business Combination, and such order or other action has become final and non-appealable; (iii) by Atlantic, following certain uncured breaches by us of our representations, warranties, covenants or agreements that would result in the failure of specified closing conditions; (iv) by us, following certain uncured breaches by Atlantic of its representations, warranties, covenants or agreements that would result in the failure of specified closing conditions; (v) by us, if there shall have been a Material Adverse Effect on the Target Companies following the date of the Atlantic BCA which is uncured and continuing; (vi) by either Atlantic or us if the SPAC Extraordinary General Meeting is held and the Required SPAC Shareholder Approval is not obtained; or (vii) by either Atlantic or us if the Atlantic Special Meeting is held and the Required Atlantic Stockholder Approval is not obtained, or if Atlantic solicits the Atlantic Written Consent and the Atlantic Stockholders holding a sufficient number of shares to constitute the Required Atlantic Stockholder Approval fail to deliver the Atlantic Written Consent within fifteen (15) Business Days following the date on which the Company first solicits such consent, subject to the limitations set forth in the Atlantic BCA.
If the Atlantic BCA is terminated, all further obligations of the parties under the Atlantic BCA (except for certain obligations related to public announcements, confidentiality, effect of termination, fees and expenses, trust account waiver, and customary miscellaneous provisions) will terminate, and no party to the Atlantic BCA will have any further liability to any other party thereto except for liability for fraud or for willful breach of the Atlantic BCA prior to such termination.
Fees and Expenses
All expenses incurred in connection with the Atlantic BCA and the transactions contemplated thereby prior to the date of the Atlantic BCA shall be paid by the party incurring such expenses; and from and after the date of the Atlantic BCA and prior to the Closing, all of our reasonable expenses incurred during such period in connection with the Atlantic BCA and the transactions contemplated thereby shall be the responsibility of Atlantic, regardless of whether the Closing occurs; provided that (i) if the Closing occurs, the combined public company will be responsible for, and will pay or reimburse us for, the unpaid expenses incurred by us from available funds, including cash remaining in the Trust Account after payment of the Redemption and the proceeds of any Transaction Financing, to the extent that we have first exhausted all of our available working capital maintained outside of the Trust Account, (ii) all fees, costs and expenses (including filing fees) under any applicable antitrust laws shall be shared equally between the parties, (iii) all fees, costs and expenses (including filing fees and printer costs) in connection with filing the Atlantic Registration Statement shall be shared equally between the parties, and (iv) all fees, costs and expenses (including filing fees) in connection with a stock exchange listing application shall be shared equally between the parties. Atlantic shall fund our expenses payable prior to the Closing by making loans to us under a single unsecured, non-interest bearing promissory note, in a form to be mutually agreed by us and Atlantic during the Interim Period, up to an aggregate outstanding principal amount of One Million Dollars ($1,000,000).
Trust Account Waiver
Each of Atlantic and Seller Representative agreed that it and its respective affiliates will not have any right, title, interest or claim of any kind in or to any monies in our trust account held for its public shareholders, and has agreed not to, and waived any right to, make any claim against the trust account (including any distributions therefrom).
Governing Law
The Atlantic BCA is governed by Delaware law, and the parties are subject to the exclusive jurisdiction of the Court of Chancery of the State of Delaware in and for New Castle County, Delaware or, if such court does not have jurisdiction, any federal court located in the State of Delaware or other Delaware state court (or, in each case, any appellate court thereof); provided that our internal corporate and constitutional matters prior to the Domestication shall be governed by the Laws of the Cayman Islands.
27
Related Agreements
Company Support Agreement
Simultaneously with the execution of the Atlantic BCA, AHPC Holding LLC (the “Atlantic Support Stockholder”), a significant stockholder of Atlantic holding capital stock of Atlantic sufficient to approve the adoption of Atlantic BCA and approve the Merger and the other transactions contemplated by the Atlantic BCA, entered into a voting and support agreement (the “Atlantic Support Agreement”), pursuant to which, among other things, the Atlantic Support Stockholder agreed to vote its shares of capital stock of Atlantic (the “Subject Stock”) in favor of the adoption of the Atlantic BCA, the ancillary documents, the approval of the Merger and the Atlantic Business Combination, and any amendments to the Atlantic’s organizational documents in connection therewith, subject to certain customary conditions. The Atlantic Support Stockholder also agreed to take certain other actions in support of the Atlantic BCA and the Atlantic Business Combination, including executing and delivering certain ancillary documents contemplated by the Atlantic BCA, and to refrain from taking actions that would adversely affect its ability to perform Atlantic Support Stockholder’s obligations under the Atlantic Support Agreement, and the Atlantic Support Stockholder unconditionally and irrevocably waived any and all pre-emption rights, rights of first offer, rights of first refusal, rights of participation, tag-along rights and all other similar rights that the Atlantic Support Stockholder may have in respect of the Atlantic Business Combination. The Atlantic Support Stockholder also agreed not to transfer its Subject Stock during the period from and including the date of the Atlantic Support Agreement and through and including the date on which the Atlantic Support Agreement is terminated, subject to certain customary exceptions.
Sponsor Support Agreement
Simultaneously with the execution of the Atlantic BCA, us, Atlantic and the Sponsor entered into a support agreement (the “Sponsor Support Agreement”), pursuant to which the Sponsor agreed, among other things, to (A) vote in favor of, take all actions necessary to consummate and otherwise support, the Atlantic Business Combination, and (B) waive any anti-dilution or similar protection with respect to the Founder Shares. In addition to the foregoing, the Sponsor Support Agreement provides that the Sponsor shall fully comply with the transfer restrictions set forth in the Insider Letter (as defined below) with respect to our securities held by the Sponsor, subject to certain limited exceptions set forth in the Insider Letter.
Lock-Up Agreements
Simultaneously with the execution of the Atlantic BCA, all stockholders of Atlantic, including officers or directors of Atlantic who own shares of Atlantic Common Stock, entered into a lock-up agreement (each, a “Lock-Up Agreement”) with us and the SPAC Representative, pursuant to which 70% of the shares of SPAC Common Stock received by each such Atlantic Stockholder as Merger Consideration will be subject to transfer restrictions for a period commencing from the Closing and ending on the date that is six months after the Closing Date (subject to early release on the earlier of (x) the date on which the closing price of the SPAC Common Stock equals or exceeds $15.00 for any 20 trading days within any 30 trading day period after the Closing and (y) the date after the Closing on which we consummate a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of its stockholders having the right to exchange their shares for cash, securities or other property), subject to certain customary transfer exceptions.
Non-Competition and Non-Solicitation Agreement
Simultaneously with the execution and delivery of the Atlantic BCA, each of Jacqueline Jiang and Tian Sheng Tan (each, a “Subject Party”) entered into a Non-Competition and Non-Solicitation Agreement (each, a “Non-Competition Agreement”) in favor of us and Atlantic (the “Covered Parties”), pursuant to which each Subject Party agreed for a period of three years after the Closing not to compete with the Covered Parties and not to solicit the employees, customers and suppliers of the Covered Parties, subject to the limitations set forth in the applicable Non-Competition Agreement.
Insider Letter Amendment
Simultaneously with the execution of the Atlantic BCA, us, the Sponsor, our directors and officers and IB Capital, entered into an amendment (the “Insider Letter Amendment”) to the Letter Agreement. The Insider Letter Amendment provides that, effective upon the Closing, the transfer restrictions set forth in the Letter Agreement will not apply to 30% of each of the Founder Shares, Private Placement Shares and shares issued in exchange for the Private Placement Rights in connection with the Closing, in each case held by the Sponsor and each Insider.
Employment Agreement
On September 3, 2026, we entered into an employment agreement (the “Employment Agreement”) with Calvin Kung, our Chief Executive Officer. Pursuant to the Employment Agreement, Mr. Kung will receive a base salary at the rate of $7,000, payable on the first day of each month following the execution of this Employment Agreement, and a one-time signing bonus of $14,000, payable upon the execution of the Employment Agreement.
28
Consulting Agreement
On September 3, 2026, we entered into a consulting agreement (the “Consulting Agreement”) with Daniel Zhao, our Chief Financial Officer. Pursuant to the Consulting Agreement, Mr. Zhao will receive a consulting fee of $3,000 per month, payable on the first day of each month following the execution of the Consulting Agreement, and a one-time signing bonus of $6,000, payable within ten (10) business days following the execution of the Consulting Agreement.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities since September 10, 2025 (inception) through September 30, 2026 have been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering and (y) identifying and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after completion of our initial Business Combination. We have generated non-operating income in the form of interest income on investments held in the Trust Account after the Initial Public Offering. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.
For the three months ended September 30, 2026, we had net income of $125,062, which consisted of $937,605 of income earned on cash and marketable securities held in the Trust Account, $3,667 of interest income earned on bank account, offset by $67,187 of formation, general and administrative expenses, $700,882 of legal and accounting expenses, which consisted of fees incurred in connection with the proposed Business Combination, $18,513 of insurance expense, $23,378 of listing fees, and $6,250 of administrative services fee – related party.
For the nine months ended September 30, 2026, we had net income of $158,254, which consisted of $1,294,504 of income earned on cash and marketable securities held in the Trust Account, $4,497 of interest income earned on bank account, offset by $184,674 of formation, general and administrative expenses, $811,747 of legal and accounting expenses, which consisted of fees incurred in connection with the proposed Business Combination, $26,562 of insurance expense, $108,288 of listing fees, and $9,476 of administrative services fee – related party.
For the period from September 10, 2025 (inception) through September 30, 2025, we had net loss of $32,246 related to formation, general and administrative expenses.
Liquidity, Capital Resources and Going Concern
As of September 30, 2026 and December 31, 2025, we had $172,161 and $44,390 of cash, respectively, and a working capital deficit of $345,326 and $205,605, respectively.
For the nine months ended September 30, 2026, net cash used in operating activities was $594,113. Net income of $158,254 was increased by a $542,137 increase in operating assets and liabilities, offset by $1,294,504 of interest income on the Trust Account.
The Company has until May 22, 2027 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution.
Further, the Company expects to incur significant costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,”, Management has determined that the Company does not have sufficient liquidity to meet its current obligations, which is considered to be one year from the date of the issuance of the accompanying unaudited financial statements. In addition, Management has determined that if the Company is unable to complete a Business Combination within the Combination Period, then the Board would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. The accompanying unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Founder Shares
On September 30, 2025, the Company issued an aggregate of 3,828,082 Founder Shares in exchange for a $25,000 payment (approximately $0.008 per share) from the Sponsor to cover certain expenses on behalf of the Company. Up to 499,315 of the Founder Shares were subject to complete or partial forfeiture by the Sponsor for no consideration depending on the extent to which the underwriters’ over-allotment option is exercised.
29
Prior to the Initial Public Offering, the Sponsor granted membership interests to each of three directors of the Company, the Chief Financial Officer (“CFO”), and the Chief Executive Officer (“CEO”). The membership interests received in the Sponsor correspond to an aggregate of 778,000 Founder Shares, to be distributed to the directors, CFO, and CEO upon consummation of a Business Combination. Each Founder Share will automatically convert to one Class A Ordinary Share concurrently with or immediately following the consummation of a Business Combination. The Sponsor will retain all voting and dispositive power over all Founder Shares until the consummation of the Business Combination, after which the Sponsor will distribute to each holder of the membership interests its share of the Founder Shares, subject to applicable lock-up restrictions.
The sale of the membership interests to the Company’s directors is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 778,000 Founder Shares granted to the Company’s directors was $700,000 or $0.90 per share. 728,000 of the Founder Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2026, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized related to these 728,000 Founder Shares. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founder Shares multiplied by the grant date fair value per share (unless subsequently modified). The remaining 50,000 Founder Shares that were granted to a director were fully vested on the grant date and related to the recipient’s contributions to the launch of the SPAC through the date of the Initial Public Offering, with no additional performance conditions.
The Founder Shares are identical to the Public Shares included in the Units that were sold in the Initial Public Offering except that the Founder Shares automatically convert into Class A Ordinary Shares at the time of the initial Business Combination (with such conversion taking place immediately prior to, simultaneously with, or immediately following the time of the initial Business Combination). The Sponsor agreed to forfeit up to an aggregate of 499,315 Founder Shares to the extent that the Over-Allotment Option is not exercised in full by the Underwriters so that the Founder Shares will represent approximately 27% of the Company’s issued and outstanding Ordinary Shares after the Initial Public Offering (excluding the Private Placement Shares and representative shares). On May 22, 2026, the Over-Allotment Option was partially exercised as part of the closing of the Initial Public Offering, and the Underwriters waived the remainder of their Over-Allotment Option. As such, 443,836 Class B Ordinary Shares are no longer subject to forfeiture and the Sponsor forfeited the remaining 55,479 Class B Ordinary Shares on May 22, 2026.
The Sponsor will not be entitled to redemption rights with respect to any Founder Shares and any Public Shares held by the Sponsor in connection with the completion of the initial Business Combination. If the initial Business Combination is not completed within 12 months from the closing of the Initial Public Offering, the Sponsor will not be entitled to rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by it.
The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $15.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property.
IPO Promissory Note — Related Party
On September 30, 2025, the Company and the Sponsor entered into a loan agreement, whereby the Sponsor agreed to loan the Company an aggregate of up to $500,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note. The IPO Promissory Note is non-interest bearing and payable on the earlier of June 30, 2026 or the date on which the Company consummates the Initial Public Offering. As of the consummation of the Initial Public Offering, the Company borrowed $237,689 under the IPO Promissory Note. In connection with the consummation of the Initial Public Offering and Private Placement on May 22, 2026, $262,389 of proceeds were used to repay the IPO Promissory Note in full, resulting in an overpayment of $24,700. As of September 30, 2026, borrowings under the IPO Promissory are no longer available subsequent to the consummation of the Initial Public Offering.
30
Due From Related Party
The Company has a $15,625 receivable from the Sponsor as of September 30, 2026 related to payments made on behalf of the Sponsor of $401, as well as an overpayment of $24,700 related to the IPO Promissory Note noted above, and offset by administrative services fee payable of $9,476. The amounts are expected to be repaid in full.
Working Capital Loans
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us Working Capital Loans, as may be required. If we complete a Business Combination, we intend to repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account will be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00 per unit. Such units (and underlying securities) would be identical to the Private Placement Units (and underlying securities). As of September 30, 2026 and December 31, 2025, the Company had no borrowings under any Working Capital Loans.
Going Concern
In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern”, Management has determined that the Company does not have sufficient liquidity to meet its current obligations for a period of one year from the date the unaudited financial statements are issued, as we expect to continue to incur significant costs in pursuit of our acquisition plans. In addition, Management has determined that if we are unable to complete an initial Business Combination within the Combination Period, then we will cease all operations except for the purpose of liquidating. These conditions raise substantial doubt about our ability to continue as a going concern. Management plans to consummate an initial Business Combination prior to the end of the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after May 22, 2027. There can be no assurance that our plans to raise capital or to consummate an initial Business Combination will be successful.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as follows:
Administrative Services Agreement
Commencing on May 20, 2026, and until the completion of our Business Combination or liquidation, we may reimburse our Sponsor $2,083 per month for office space, utilities and secretarial and administrative support pursuant to the Administrative Services Agreement.
Underwriting Agreement
We granted the Underwriters a 30-day option from the date of the Initial Public Offering to purchase up to an additional 1,350,000 Option Units to cover over-allotments, if any. On May 22, 2026 the Underwriters partially exercised their Over-Allotment Option. The Underwriters waived and forfeited the remainder of their Over-Allotment Option to purchase up to an additional 150,000 Option Units on May 22, 2026.
The Underwriters were paid a cash underwriting discount of $0.15 per Unit, or $1,530,000 in the aggregate, upon the closing of the Initial Public Offering.
Representative Shares
We issued 450,000 Representative Shares to the Underwriters or their designees, at the consummation of the Initial Public Offering. We account for the Representative Shares as an offering cost of the Initial Public Offering, resulting in a charge directly to shareholders’ equity. The holders of the Representative Shares have agreed not to transfer, assign or sell any such Representative Shares without prior consent until the completion of the initial Business Combination. In addition, the holders of the Representative Shares have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to such Representative Shares in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if we fail to complete the initial Business Combination within the Combination Period.
31
The Representative Shares have been deemed compensation by the Financial Industry Regulatory Authority (“FINRA”) and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of IPO Registration Statement pursuant to Rule 5110(e)(1) of the FINRA Manual. Pursuant to FINRA Rule 5110(e)(1), these securities were not sold during the Initial Public Offering, and cannot be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the IPO Registration Statement or commencement of sales in the Initial Public Offering, except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners, provided that all securities so transferred remain subject to the lockup restriction above for the remainder of the time period.
Registration Rights Agreement
The holders of (i) the Founder Shares, (ii) the Private Placement Units, (iii) any private placement-equivalent units issued in connection with the Working Capital Loans, if any and (iv) the Representative Shares (and in each case holders of their underlying securities, as applicable) are entitled to registration rights pursuant to the Registration Rights Agreement, requiring us to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A Ordinary Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. The Underwriters may only make a demand on one occasion and only during the five-year period beginning on the effective date of the IPO Registration Statement. In addition, the Underwriters may participate in a “piggyback” registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. We will bear the expenses incurred in connection with the filing of any such registration statements.
Letter Agreement
Our Sponsor, directors and officers have entered into the Letter Agreement with us, pursuant to which, they have waived their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if we fail to complete our initial Business Combination within the Combination Period. However, if they acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if we fail to complete our initial Business Combination within the Combination Period.
Additionally, pursuant to the Letter Agreement, our Sponsor, directors and officers will not propose any amendment to our Amended and Restated Articles to modify (i) the substance or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of our Public Shares if we do not complete our initial Business Combination within the Combination Period or (ii) any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, unless we provide our Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, divided by the number of then outstanding Public Shares.
Furthermore, pursuant to the Letter Agreement, our Sponsor, directors, officers have agreed that: (x) the Founder Shares shall be subject to a transfer restrictions of the earlier of (i) six months after the completion of our initial Business Combination or earlier if, subsequent to our initial Business Combination, the closing price of the Class A Ordinary Shares equals or exceeds $15.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 30 days after our initial Business Combination and (ii) the date following the completion of our initial Business Combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property; (y) the Private Placement Units (including their underlying securities) shall be subject to transfer restriction until 30 days after the completion of our initial Business Combination; and (z) any Units, Rights, Ordinary Shares or any other securities convertible into, or exercisable or exchangeable for, any Units, Ordinary Shares, Founder Shares or Rights shall be subject to transfer restriction for 180 days.
Simultaneously with the execution of the Atlantic BCA, us, the Sponsor, our directors and officers and IB Capital, entered into the Inside Letter Amendment. The Insider Letter Amendment provides that, effective upon the Closing, the transfer restrictions set forth in the Letter Agreement will not apply to 30% of each of the Founder Shares, Private Placement Shares and shares issued in exchange for the Private Placement Rights in connection with the Closing, in each case held by the Sponsor and each Insider.
Critical Accounting Estimates
The preparation of the unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements” in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, income and expenses, and the disclosure of contingent assets and liabilities, in our unaudited condensed financial statements. These accounting estimates require the use of assumptions about matters, some of which are highly uncertain at the time of estimation. Management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments, and we evaluate these estimates on an ongoing basis. To the extent actual experience differs from the assumptions used, our unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements” could be materially affected. As of September 30, 2026, we did not have any critical accounting estimates to be disclosed.
32
Recent Accounting Standards
In November 2023, the FASB issued ASU Topic 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). The amendments in ASU 2023-07 require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by FASB ASC Topic 280, “Segment Reporting,” (“ASC 280”) in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in ASU 2023-07 and existing segment disclosures in ASC 280. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We adopted ASU 2023-07 on September 10, 2025, the date of our incorporation.
In December 2023, the FASB issued ASU Topic 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”), which enhances the transparency and usefulness of income tax disclosures. ASU 2023-09 will be effective for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. We adopted ASU 2023-09 on September 10, 2025, the date of our incorporation. Adoption of ASU 2023-09 did not impact our financial position, results of operations or cash flows.
Management does not believe that there are any other recently issued, but not yet effective, accounting standards, which, if currently adopted, would have a material effect on the unaudited condensed financial statements and notes thereto included in this Report under Item 1. “Financial Statements”.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective as of September 30, 2026, due to a material weakness relating to the lack of properly designed, implemented, and effectively operating controls.
Management, with oversight from the Board of Directors and the audit committee of the Board of Directors, will implement a remediation plan for this material weakness, including, among other things, designing and maintaining a formal control environment, accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures. We will also enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements including making greater use of third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. We believe our efforts will enhance our controls relating to accounting for complex financial transactions, but we can offer no assurance that our controls will not require additional review and modification in the future as industry accounting practice may evolve over time.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
Other than as discussed above, there have been no changes to our internal control over financial reporting during the quarterly period ended September 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
33
PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
To the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such, or against any of our property.
Item 1A. Risk Factors.
As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, for detailed descriptions of the risks relating to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement and (ii) Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. As of the date of this Report, there have been no material changes with respect to those risk factors, other than as set forth below. Any of these previously disclosed risk factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks not presently known to us or that we currently deem immaterial may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
There is substantial doubt about our ability to continue as a “going concern.”
We expect to continue to incur significant costs in pursuit of our acquisition plans. In connection with our assessment of going concern considerations under applicable accounting standards, Management has determined that our possible need for additional financing to enable us negotiate and complete our initial Business Combination, as well as the deadline by which we may be required to liquidate our Trust Account, raise substantial doubt about our ability to continue as a going concern through approximately one year from the date the unaudited condensed financial statements included in Item 1. “Financial Statements” of this Report were issued.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Unregistered Sales of Equity Securities
Simultaneously with the closing of the Initial Public Offering and pursuant to the Private Placement Units Purchase Agreements, we completed the sale of an aggregate of 311,000 Private Placement Units to the Sponsor and the Underwriters in the Private Placement at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to us of $3,110,000. Of those 311,000 Private Placement Units, the Sponsor purchased 223,000 Private Placement Units and the Underwriters purchased 88,000 Private Placement Units. The Private Placement Units (and underlying securities) are identical to the Public Units (and underlying securities), except as otherwise disclosed in the IPO Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Use of Proceeds
For a description of the use of proceeds generated in our Initial Public Offering and the Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the SEC on June 25, 2026. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.
To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.
The remaining proceeds from the Initial Public Offering and the Private Placement are held outside the Trust Account. Such funds are being used primarily to enable us to identify a target and to negotiate and consummate our initial Business Combination.
There has been no material change in the planned use of the proceeds from our Initial Public Offering and the Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.
34
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
There were no purchases of our equity securities by us or an affiliate during the quarterly period covered by this Report.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
There have been no material changes to the procedures by which our security holders may recommend nominees to our Board since we reported such procedures in the IPO Registration Statement.
Trading Arrangements
During the quarterly period ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act)
Additional Information
None.
35
Item 6. Exhibits.
The following exhibits are filed as part of, or incorporated by reference into, this Report.
| No. | Description of Exhibit | |
| 2.1 | Business Combination Agreement, dated as of September 10, 2026, by and among Aperture AC, AP Ocean Merger Sub, Inc., Atlantic HPC Group Inc, Aperture Sponsor LLC and AHPC Holding LLC. (1) | |
| 10.1 | Employment Agreement, dated September 3, 2026, by and between the Company and Calvin Kung. (2) | |
| 10.2 | Consulting Agreement, dated September 3, 2026, by and between the Company and Daniel Zhao. (2) | |
| 10.3 | Company Support Agreement, dated as of September 10, 2026, by and among Aperture AC, Atlantic HPC Group Inc and AHPC Holding LLC. (1) | |
| 10.4 | Sponsor Support Agreement, dated as of September 10, 2026, by and among Aperture AC, Atlantic HPC Group Inc. and Aperture Sponsor LLC. (1) | |
| 10.5 | Form of Lock-Up Agreement, dated as of September 10, 2026, by and among Aperture AC, Aperture Sponsor LLC and the holders party thereto. (1) | |
| 10.6 | Form of Non-Competition and Non-Solicitation Agreement, by and among Aperture AC, Atlantic HPC Group Inc. and the subject party thereto. (1) | |
| 10.7 | Amendment to Letter Agreement, dated as of September 10, 2026, by and among Aperture AC, Aperture Sponsor LLC, IB Capital, LLC and the insiders party thereto. (1) | |
| 31.1 | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.* | |
| 31.2 | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.* | |
| 32.1 | Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.** | |
| 32.2 | Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.** | |
| 101.INS | Inline XBRL Instance Document.* | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |
| 104 | Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).* |
| * | Filed herewith. |
| ** | Furnished herewith. |
| (1) | Incorporated by reference to the Company’s Current Report on Form 8-K, as filed with the SEC on September 16, 2026. |
| (2) | Incorporated by reference to the Company’s Current Report on Form 8-K, as filed with the SEC on September 4, 2026. |
36
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: November 13, 2026 | APERTURE AC | |
| By: | /s/ Calvin Kung | |
| Name: | Calvin Kung | |
| Title: | Chief Executive Officer | |
| (Principal Executive Officer) | ||
| Date: November 13, 2026 | By: | /s/ Daniel Zhao |
| Name: | Daniel Zhao | |
| Title: | Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
37